NIPD GENETICS NeoClaris early screening Logo (EUIPO, 07/06/2021)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark NIPD GENETICS NeoClaris early screening was filed as Figurative mark on 07/06/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 11/12/2021.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Backgrounds, in words or numerals, divided into two, three or four #Red, pink, orange #Black
| Trademark form | Figurative mark |
| File reference | 018508573 |
| Application date | July 6, 2021 |
| Publication date | August 5, 2021 |
| Entry date | November 12, 2021 |
| Expiration date | July 6, 2031 |
Trademark owner
31, Neas Engomis, Engomi,
2409 Nicosia
CY
2409 Nicosia
CY
Trademark representatives
Fasanenstr. 29
10719 Berlin
DE
goods and services
1
Kits composed of reagents for genetic testing for medical and scientific research purposes; Kits composed of reagents for genetic testing for medical and scientific research purposes in the field of oncology; Kits composed of reagents for cancer diagnosis and prognosis for medical and scientific research purposes; Kits composed of reagents for testing for chromosomal or mutational abnormalities in cancer patients for medical and scientific research purposes
42
Medical laboratory services for cancer testing; Design and development of medical diagnostic tests and products; Medical and scientific research in the field of genetic testing particularly in the field of oncology; Providing medical and scientific research information in the field of genetic testing; Genetic testing for scientific research and analysis purposes in the field of oncology cancer; Genetic engineering services
44
Medical testing services for diagnosis of cancer; Medical genetic screening testing; Medical diagnostic testing in the field of oncology; Medical testing of blood for diagnosis of genetic abnormalities such as mutations during cancer disease; Medical testing for diagnosis of genetic disorders, diseases and syndromes; Genetic testing and genetic counseling in the field of cancer treatment; Medical and health services relating to DNA, genetics and genetic testing
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| November 17, 2023 | Change Representative, Published | ||
| September 15, 2022 | Transfer / Change of address, Published | ||
| July 18, 2022 | Change Representative, Published | ||
| April 20, 2022 | Change Representative, Published |
ID: 11018508573